Skip to Content
Merck
CN

Xeno-immunogenicity of ice-free cryopreserved porcine leaflets.

The Journal of surgical research (2014-12-03)
Martina Seifert, Alexandra Bayrak, Meaghan Stolk, Naima Souidi, Maria Schneider, Ulrich A Stock, Kelvin G M Brockbank
ABSTRACT

Undesirable processes of inflammation, calcification, or immune-mediated reactions are limiting factors in long-term survival of heart valves in patients. In this study, we target the modulatory effects of ice-free cryopreservation (IFC) of xenogeneic heart valve leaflet matrices, without decellularization, on the adaptive human immune responses in vitro. We tested porcine leaflet matrices from fresh untreated, conventionally cryopreserved (CFC), and IFC pulmonary valves by culturing them with human blood mononuclear cells for 5 d in vitro. No other tissue treatment protocols to modify possible immune responses were used. Matrices alone or in addition with a low-dose second stimulus were analyzed for induction of proliferation and cytokine release by flow cytometry-based techniques. Evaluation of the α-Gal epitope expression was performed by immunohistochemistry with fluorochrome-labeled B4 isolectin. None of the tested leaflet treatment groups directly triggered the proliferation of immune cells. But when tested in combination with a second trigger by anti-CD3, IFC valves showed significantly reduced proliferation of T cells, especially effector memory T cells, in comparison with fresh or CFC tissue. Moreover, the cytokine levels for interferon-γ (IFNγ), tumor necrosis factor α, and interleukin-10 were reduced for the IFC-treated group being significantly different compared with the CFC group. However, no difference between treatment groups in the expression of the α-Gal antigen was observed. IFC of xenogeneic tissue might be an appropriate treatment method or processing step to prevent responses of the adaptive immune system.

MATERIALS
Product Number
Brand
Product Description

Supelco
Propylene glycol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
2-Methylbutane, anhydrous, ≥99%
Sigma-Aldrich
Formamide, ACS reagent, ≥99.5%
Sigma-Aldrich
Diethyl azodicarboxylate solution, 40 wt. % in toluene
Sigma-Aldrich
Formamide, ≥99.5% (GC), BioReagent, Molecular Biology
Sigma-Aldrich
Propylene Glycol, meets USP testing specifications
Sigma-Aldrich
Sodium azide, BioXtra
Sigma-Aldrich
Sodium azide, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Propylene glycol, ≥99.5% (GC), FCC, FG
Sigma-Aldrich
Formamide, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
2-Methylbutane, ReagentPlus®, ≥99%
Propylene glycol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
2-Methylbutane, suitable for HPLC, ≥99.5%
Lysine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Formamide, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Formamide, spectrophotometric grade, ≥99%
Sigma-Aldrich
2-Methylbutane, ReagentPlus®, ≥99%
Sigma-Aldrich
2-Methylbutane, puriss. p.a., ≥99.5% (GC)
USP
Propylene glycol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Formamide, Vetec, reagent grade, 98%
Supelco
2-Methylbutane, analytical standard
Supelco
L-Glutamine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
L-Lysine monohydrochloride, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Glutamine
Supelco
Dimethyl sulfoxide, for inorganic trace analysis, ≥99.99995% (metals basis)
Sigma-Aldrich
Formamide solution, suitable for NMR (reference standard), 90% in DMSO-d6 (99.9 atom % D), NMR tube size 10 mm × 8 in.
Sigma-Aldrich
1,2-Propanediol, ReagentPlus®, 99%
Supelco
Sucrose, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Glutamine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Formamide solution, suitable for NMR (reference standard), 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.